Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Jarius, Sven ^a   Martínez García, Pedro ^b   Hernandez, Adelaida León ^b   Brase, Jan Christoph ^c,d   Borowski, Kathrin ^e   Regula, Jens Ulrich ^a   Meinck, Hans Michael ^a   Stöcker, Winfried ^e   Wildemann, Brigitte ^a   Wandinger, Klaus Peter ^e,f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d Sividon Diagnostics GmbH   (Germany)

^e Institute of Experimental Immunology   (Germany)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Autoantibodies; Autoimmune cerebellar ataxia; Autoimmunity; GTPase regulator associated with focal adhesion kinase pp125 (GRAF); Oligophrenin 1 like protein; Ovarian cancer; Paraneoplastic; Purkinje cells; RhoGTPase activating protein 26 (ARHGAP26)

Indexed keywords

AUTOANTIBODY; CA 15-3 ANTIGEN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; FOCAL ADHESION KINASE 1; GRAF AUTOANTIBODY; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; OLIGOPHRENIN 1 LIKE PROTEIN; REGULATOR PROTEIN; RHO GUANINE NUCLEOTIDE BINDING ACTIVATING PROTEIN 26; RITUXIMAB; SMOOTH MUSCLE ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE CEREBELLAR ATAXIA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BALANCE IMPAIRMENT; CANCER CHEMOTHERAPY; CASE REPORT; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DIZZINESS; DYSARTHRIA; ENZYME BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GAIT DISORDER; HUMAN; HYPERPROLACTINEMIA; HYSTERECTOMY; IMMUNOASSAY; LABORATORY DIAGNOSIS; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OVARY CANCER; OVARY CARCINOMA; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN TARGETING; PURKINJE CELL; RESPIRATORY TRACT INFECTION; TREATMENT RESPONSE; TUMOR DIAGNOSIS; WALKING DIFFICULTY;

EID: 84872169664     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-7     Document Type: Article

References (21)

1. Jarius S, Wandinger KP, Horn S, Heuer H, Wildemann B. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization. J Neuroinflammation 2010, 7:21. 10.1186/1742-2094-7-21, 2848133, 20226058.
2. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuuren JJ, Vincent A, Voltz R. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004, 75:1135-1140. 10.1136/jnnp.2003.034447, 1739186, 15258215.
3. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 2002, 1:294-305. 10.1016/S1474-4422(02)00135-7, 12849427.
4. Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, Berglund L, Bergstrom K, Brumer H, Cerjan D, Ekstrom M, Elobeid A, Eriksson C, Fagerberg L, Falk R, Fall J, Forsberg M, Bjorklund MG, Gumbel K, Halimi A, Hallin I, Hamsten C, Hansson M, Hedhammar M, Hercules G, Kampf C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005, 4:1920-1932. 10.1074/mcp.M500279-MCP200, 16127175.
5. Graus F, Keime-Guibert F, Rene R, Benyahia B, Ribalta T, Ascaso C, Escaramis G, Delattre JY. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001, 124:1138-1148. 10.1093/brain/124.6.1138, 11353730.
6. Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992, 42:1931-1937. 10.1212/WNL.42.10.1931, 1407575.
7. Honnorat J, Antoine JC, Belin MF. Are the "newly discovered" paraneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies?. Ann Neurol 2001, 50:688-691.
8. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001, 49:146-154. 10.1002/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E, 11220734.
9. Trotter JL, Hendin BA, Osterland CK. Cerebellar degeneration with Hodgkin disease. An immunological study. Arch Neurol 1976, 33:660-661. 10.1001/archneur.1976.00500090066014, 962649.
10. Graus F, Dalmau J, Valldeoriola F, Ferrer I, Rene R, Marin C, Vecht CJ, Arbizu T, Targa C, Moll JW. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997, 74:55-61. 10.1016/S0165-5728(96)00205-6, 9119979.
11. Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR, Dalmau J. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 2004, 62:778-782. 10.1212/01.WNL.0000113749.77217.01, 2574539, 15007130.
12. Sabater L, Bataller L, Carpentier AF, Aguirre-Cruz ML, Saiz A, Benyahia B, Dalmau J, Graus F. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J Neurol Neurosurg Psychiatry 2006, 77:1359-1362. 10.1136/jnnp.2006.097188, 2077410,2077410, 16801349.
13. Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, Henzen-Logmans S, Vecht C, De Zeeuw C, Sekiyama N, Nakanishi S, Shigemoto R. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 2000, 342:21-27. 10.1056/NEJM200001063420104, 10620645.
14. Coesmans M, Smitt PA, Linden DJ, Shigemoto R, Hirano T, Yamakawa Y, van Alphen AM, Luo C, van der Geest JN, Kros JM, Gaillard CA, Frens MA, de Zeeuw CI. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies. Ann Neurol 2003, 53:325-336. 10.1002/ana.10451, 12601700.
15. Vernino S, Lennon VA. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 2000, 47:297-305. 10.1002/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4, 10716248.
16. Chan KH, Vernino S, Lennon VA. ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 2001, 50:301-311. 10.1002/ana.1127, 11558786.
17. Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 2002, 59:764-766. 10.1212/WNL.59.5.764, 12221175.
18. Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, Hart IK, Honnorat J, Sillevis Smitt PA, Verschuuren JJ, Voltz R. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 2006, 13:682-690. 10.1111/j.1468-1331.2006.01266.x, 16834698.
19. Hofsli E, Wheeler TE, Langaas M, Laegreid A, Thommesen L. Identification of novel neuroendocrine-specific tumour genes. Br J Cancer 2008, 99:1330-1339. 10.1038/sj.bjc.6604565, 2570516, 18827820.
20. Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 2010, 6:383-392. 10.1038/nrneurol.2010.72, 20639914.
21. Jarius S, Franciotta D, Bergamaschi R, Wildemann B, Wandinger KP. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Clin Chem Lab Med 2010, 48:659-663.